Table 1.
The amount of oxi- Met 3 - γ-synuclein –positive astrocytes in patients with NDDs and control individuals
| Patient’s ID | Sex | Age | Diagnosis | Number of oxi-Met 38 -γ-syn–positive astrocytes |
|---|---|---|---|---|
| K33 | M | 76 | DLB | + |
| K11 | F | 87 | AD with DLB related pathology | + |
| K13 | M | 85 | DLB | ++ |
| K39 | M | 74 | DLB | + |
| S3 | M | 73 | DLB + mild AD | +++ |
| S4 | F | 87 | AD with DLB related pathology | ++ |
| PD1 | M | 55 | PD | ++ |
| PD2 | M | 85 | PD | ++++ |
| K21 | M | 97 | Control | ++ |
| K35 | F | 61 | Control | + |
| K41 | F | 61 | Control | ++ |
| K45 | M | 66 | Control | + |
| K46 | M | 79 | Control | +++ |
| K48 | F | 88 | Control | +++ |
The patients were selected based on the neuropathological characteristics. The number of oxi-Met38 –positive astrocytes was calculated on a 2 x 2.5 cm slice.
+ represents the number of oxi-Met38 –positive astrocytes from 1 to 2.
++ represent the number of oxi-Met38 –positive astrocytes from 2 to 5.
+++ represent the number of oxi-Met38 –positive astrocytes from 5 to10.
++++ represent the number of oxi-Met38 –positive astrocytes > 10.